•  26
    Research With Controlled Drugs: Why and Why Not? Response to Open Peer Commentaries on “An Ethical Exploration of Barriers to Research on Controlled Drugs”
    with Michael H. Andreae, Evelyn Rhodes, George M. Carter, Robert S. White, Debbie Indyk, Henry Sacks, and Rosamond Rhodes
    American Journal of Bioethics 16 (4): 1-3. 2016.
    We examine the ethical, social, and regulatory barriers that may hinder research on therapeutic potential of certain controversial controlled substances like marijuana, heroin, or ketamine. Hazards for individuals and society and potential adverse effects on communities may be good reasons for limiting access and justify careful monitoring of these substances. Overly strict regulations, fear of legal consequences, stigma associated with abuse and populations using illicit drugs, and lack of fund…Read more